Acquisition of a new primary healthcare centre

By

Regulatory News | 22 Dec, 2017

Updated : 07:31

RNS Number : 1509A
The MedicX Fund Limited
22 December 2017
 

 

 

For immediate release                                                                                    

22 December 2017

 

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

 

Acquisition of a new primary healthcare centre

 

MedicX Fund, (LSE: MXF), the specialist primary care infrastructure investor in modern, purpose-built, primary healthcare properties in the United Kingdom and Ireland, is pleased to announce the Company's fifth acquisition in Ireland. Ayrfield Medical Park in Kilkenny is a standing investment and has been purchased by way of a sale and leaseback to the doctors who developed the centre in 2011.  

In addition to the large GP practice, the 2,700 sq m building is let to the Health Service Executive (the Irish NHS equivalent), a pharmacy operator, a dental practitioner, a cafe and several other complementary healthcare providers. The GPs and Health Service Executive leases have over 18 years remaining and the pharmacy and dental operators have long leasehold interests. The rents are subject to five-yearly CPI reviews. The total acquisition cost of the property is approximately €7.8 million. 

MedicX Fund's total property portfolio now comprises 153 properties throughout the United Kingdom and Ireland of which 147 are operational and let, with six under construction. 

End

 

For further information please contact:

 

MedicX Fund                                                                   +44 (0) 1481 723 450

David Staples, Chairman

 

Octopus Healthcare Group                                               +44 (0) 20 3142 4820

Mike Adams, Chief Executive Officer

 

Buchanan                                                                        +44 (0) 20 7466 5000

Charles Ryland/Vicky Hayns

 

Information on MedicX Fund Limited

 

MedicX Fund Limited (the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, listed on the London Stock Exchange, with a portfolio comprising 153 properties.

 

The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is part of the Octopus Healthcare group. Octopus Healthcare invests in and develops properties as well as creating partnerships to deliver innovative healthcare buildings to improve the health, wealth and wellbeing of the UK. It currently manages over £1.2 billion of healthcare investments across a number of platforms, with a focus on five core areas: GP surgeries, care homes, special education schools, retirement housing and private hospitals. Octopus Healthcare is part of the Octopus group, a fast-growing UK fund management business with leading positions in several specialist sectors including healthcare property, energy, property finance and smaller company investing. Octopus manages £7 billion of funds for more than 50,000 retail and institutional investors as well as supplying energy to more than 100,000 customers

 

Octopus Healthcare Adviser Ltd is authorised and regulated by the Financial Conduct Authority.

 

The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

 

The Company's Legal Entity Identifier is 2138008POF35FTNFCB25.

 

 

 

 

 

 

 

 

 

 

                                                     


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQFFLLLDLFLFBB

Last news